Glenzocimab Biosimilar (GP6 / Glycoprotein-6 Reference Antibody)
Glenzocimab (ACT017) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke.
Product Specifications
Target
Glenzocimab Biosimilar (Anti-GP6 / Glycoprotein-6 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog